Talk:Erdheim–Chester disease
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Erdheim–Chester disease.
|
Quote or paraphrase to avoid plagiarism
editSince the text of the lead is almost identical to the cited reference at http://www.diseasesdatabase.com/umlsdef.asp?glngUserChoice=29792, should this be explicitly quoted in the article? Otherwise, it might be best to rephrase the lead. zadignose (talk) 14:20, 28 April 2008 (UTC)
Two months later, I've explicitly made this a quote, and gone to the source it was lifted from. Rewrite it, preferably in less abstruse language, if you want to remove the explicit citation. zadignose (talk) 15:05, 18 June 2008 (UTC)
P.S. Also note that this text could likely be deleted if it can not be paraphrased, or a Free-Documentation-License can not be provided. zadignose (talk) 15:07, 18 June 2008 (UTC)
Reword
editThis article uses 'involvement' without being specific. Examples should be given and the article reworded. — Preceding unsigned comment added by 78.149.44.134 (talk) 17:25, 20 August 2011 (UTC)
Guideline
editdoi:10.1182/blood-2014-03-561381 JFW | T@lk 10:37, 27 July 2014 (UTC)
Updating a sentence
editThis line "Approximately 500 cases have been reported in the literature to date.[17]" can be edited to include a new source article, Erdheim-Chester Disease: a Concise Review, from 2019 that claims there are 1500 reported cases worldwide. 192.44.242.208 (talk) 13:42, 2 March 2022 (UTC)
Prognosis
editThere is a call for a Reference in this section. I don't know enough about Wikipedia to add this, but a believe a relevant reference is:
Journal of Clinical Oncology > List of Issues > Volume 38, Issue 15_suppl >
Meeting Abstract | 2020 ASCO Annual Meeting I
HEMATOLOGIC MALIGNANCIES—LEUKEMIA, MYELODYSPLASTIC SYNDROMES, AND ALLOTRANSPLANT Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2020.38.15_suppl.7560 Journal of Clinical Oncology - published online before print May 25, 2020
Long-term outcome of 117 patients with Erdheim-Chester disease and mixed histiocytosis receiving targeted therapies (BRAF and MEK inhibitors): A monocentric experience. — Preceding unsigned comment added by 80.193.244.222 (talk) 15:14, 24 March 2022 (UTC)